| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.881 | 0.003 | 0.885 | Psychostimulant | 0.885 0.003 DBMET03499 | DBMET03499 | |
| 0.821 | 0.002 | 0.821 | Neuropeptide Y2 antagonist | 0.702 0.003 DBMET03499 | ||
| 0.726 | 0.002 | 0.775 | Insulysin inhibitor | 0.775 0.002 DBMET03499 | DBMET03499 | |
| 0.668 | 0.01 | 0.684 | Immunostimulant | 0.684 0.009 DBMET03499 | DBMET03499 | |
| 0.541 | 0.002 | 0.541 | Neurotensin receptor agonist | 0.54 0.002 DBMET03499 | ||
| 0.554 | 0.015 | 0.564 | Interleukin antagonist | 0.564 0.015 DBMET03499 | DBMET03499 | |
| 0.494 | 0.005 | 0.494 | Thrombolytic | 0.491 0.005 DBMET03499 | ||
| 0.515 | 0.027 | 0.556 | Antithrombotic | 0.556 0.021 DBMET03499 | DBMET03499 | |
| 0.456 | 0.002 | 0.599 | Melanocortin 1 antagonist | 0.599 0.001 DBMET03499 | DBMET03499 | |
| 0.438 | 0.006 | 0.493 | Hemostatic | 0.493 0.004 DBMET03499 | DBMET03499 | |
| 0.431 | 0.014 | 0.439 | Anticoagulant | 0.439 0.014 DBMET03499 | DBMET03499 | |
| 0.415 | 0.019 | 0.421 | Angiogenesis stimulant | 0.421 0.019 DBMET03499 | DBMET03499 | |
| 0.403 | 0.009 | 0.403 | Calpain inhibitor | 0.373 0.013 DBMET03499 | ||
| 0.385 | 0.023 | 0.494 | Transcription factor STAT inhibitor | 0.494 0.008 DBMET03499 | DBMET03499 | |
| 0.38 | 0.034 | 0.383 | Interleukin 2 agonist | 0.383 0.033 DBMET03499 | DBMET03499 | |
| 0.345 | 0.004 | 0.345 | Neuropeptide Y1 antagonist | 0.307 0.005 DBMET03499 | ||
| 0.359 | 0.022 | 0.365 | Growth hormone agonist | 0.365 0.021 DBMET03499 | DBMET03499 | |
| 0.333 | 0.002 | 0.335 | Bombesin 2 receptor antagonist | 0.335 0.002 DBMET03499 | DBMET03499 | |
| 0.361 | 0.036 | 0.361 | Platelet antagonist | 0.359 0.036 DBMET03499 | ||
| 0.341 | 0.036 | 0.396 | Transcription factor STAT3 inhibitor | 0.396 0.019 DBMET03499 | DBMET03499 | |
| 0.287 | 0.005 | 0.287 | Falcipain 3 inhibitor | 0.282 0.005 DBMET03499 | ||
| 0.282 | 0.003 | 0.282 | Gonadotropin-releasing hormone receptor agonist | 0.243 0.003 DBMET03499 | ||
| 0.331 | 0.067 | 0.344 | Immunomodulator | 0.344 0.062 DBMET03499 | DBMET03499 | |
| 0.265 | 0.004 | 0.265 | Gonadotropin-releasing hormone receptor antagonist | 0.258 0.004 DBMET03499 | ||
| 0.281 | 0.021 | 0.287 | Thiol protease inhibitor | 0.287 0.021 DBMET03499 | DBMET03499 | |
| 0.32 | 0.073 | 0.32 | Apoptosis antagonist | 0.312 0.078 DBMET03499 | ||
| 0.238 | 0.007 | 0.248 | Hematopoietic | 0.248 0.006 DBMET03499 | DBMET03499 | |
| 0.235 | 0.005 | 0.324 | Melanocortin 3 antagonist | 0.324 0.004 DBMET03499 | DBMET03499 | |
| 0.236 | 0.02 | 0.266 | Histone deacetylase SIRT1 inhibitor | 0.266 0.014 DBMET03499 | DBMET03499 | |
| 0.219 | 0.005 | 0.335 | Melanocortin 4 antagonist | 0.335 0.004 DBMET03499 | DBMET03499 | |
| 0.216 | 0.006 | 0.216 | Neurotensin receptor antagonist | 0.215 0.006 DBMET03499 | ||
| 0.214 | 0.006 | 0.306 | Melanocortin antagonist | 0.306 0.005 DBMET03499 | DBMET03499 | |
| 0.218 | 0.015 | 0.224 | Nav1.4 sodium channel blocker | 0.224 0.014 DBMET03499 | DBMET03499 | |
| 0.209 | 0.016 | 0.237 | Histone deacetylase class III inhibitor | 0.237 0.011 DBMET03499 | DBMET03499 | |
| 0.212 | 0.022 | 0.212 | Proteasome inhibitor | 0.192 0.028 DBMET03499 | ||
| 0.241 | 0.053 | 0.25 | Platelet adhesion inhibitor | 0.25 0.049 DBMET03499 | DBMET03499 | |
| 0.175 | 0.005 | 0.239 | Melanocortin 1 agonist | 0.239 0.004 DBMET03499 | DBMET03499 | |
| 0.186 | 0.017 | 0.192 | Opioid antagonist | 0.192 0.015 DBMET03499 | DBMET03499 | |
| 0.183 | 0.014 | 0.191 | Opioid delta receptor antagonist | 0.191 0.012 DBMET03499 | DBMET03499 | |
| 0.176 | 0.007 | 0.177 | Neuropeptide agonist | 0.177 0.007 DBMET03499 | DBMET03499 | |
| 0.313 | 0.146 | 0.404 | Calcium channel L-type activator | 0.404 0.079 DBMET03499 | DBMET03499 | |
| 0.161 | 0.005 | 0.226 | Melanocortin agonist | 0.226 0.004 DBMET03499 | DBMET03499 | |
| 0.161 | 0.007 | 0.164 | Bombesin 1 receptor agonist | 0.164 0.007 DBMET03499 | DBMET03499 | |
| 0.183 | 0.029 | 0.183 | Adenylate cyclase inhibitor | 0.178 0.031 DBMET03499 | ||
| 0.158 | 0.007 | 0.161 | Glucagon-like peptide 1 agonist | 0.161 0.007 DBMET03499 | DBMET03499 | |
| 0.228 | 0.082 | 0.228 | Antiamyloidogenic | 0.17 0.123 DBMET03499 | ||
| 0.158 | 0.016 | 0.166 | Opioid mu receptor antagonist | 0.166 0.014 DBMET03499 | DBMET03499 | |
| 0.174 | 0.041 | 0.185 | Neurotrophic factor | 0.185 0.035 DBMET03499 | DBMET03499 | |
| 0.158 | 0.028 | 0.162 | Falcipain inhibitor | 0.162 0.026 DBMET03499 | DBMET03499 | |
| 0.134 | 0.005 | 0.17 | Melanocortin 5 agonist | 0.17 0.004 DBMET03499 | DBMET03499 | |
| 0.147 | 0.02 | 0.148 | Factor V inhibitor | 0.148 0.019 DBMET03499 | DBMET03499 | |
| 0.133 | 0.005 | 0.143 | Calcitonin receptor agonist | 0.143 0.003 DBMET03499 | DBMET03499 | |
| 0.14 | 0.015 | 0.142 | Factor XII inhibitor | 0.142 0.015 DBMET03499 | DBMET03499 | |
| 0.17 | 0.046 | 0.17 | Bone formation stimulant | 0.166 0.048 DBMET03499 | ||
| 0.137 | 0.013 | 0.138 | Thrombin inhibitor | 0.138 0.013 DBMET03499 | DBMET03499 | |
| 0.151 | 0.028 | 0.156 | Falcipain 2 inhibitor | 0.156 0.026 DBMET03499 | DBMET03499 | |
| 0.127 | 0.004 | 0.199 | Melatonin 3 antagonist | 0.199 0.004 DBMET03499 | DBMET03499 | |
| 0.138 | 0.017 | 0.157 | CXC chemokine 4 receptor antagonist | 0.157 0.014 DBMET03499 | DBMET03499 | |
| 0.198 | 0.079 | 0.198 | Amyloid beta aggregation inhibitor | 0.18 0.089 DBMET03499 | ||
| 0.208 | 0.089 | 0.22 | Peptidyltransferase inhibitor | 0.22 0.076 DBMET03499 | DBMET03499 | |
| 0.124 | 0.006 | 0.132 | Histone deacetylase SIRT3 inhibitor | 0.132 0.005 DBMET03499 | DBMET03499 | |
| 0.22 | 0.103 | 0.253 | Interleukin agonist | 0.253 0.077 DBMET03499 | DBMET03499 | |
| 0.121 | 0.005 | 0.168 | Melanocortin 4 agonist | 0.168 0.005 DBMET03499 | DBMET03499 | |
| 0.126 | 0.01 | 0.126 | Protease activated receptor 1 antagonist | 0.112 0.012 DBMET03499 | ||
| 0.117 | 0.005 | 0.126 | Bombesin antagonist | 0.126 0.005 DBMET03499 | DBMET03499 | |
| 0.154 | 0.043 | 0.154 | Cathepsin H inhibitor | 0.153 0.044 DBMET03499 | ||
| 0.138 | 0.036 | 0.138 | Protease inhibitor | 0.138 0.036 DBMET03499 | ||
| 0.1 | 0.005 | 0.145 | Melanocortin 3 agonist | 0.145 0.004 DBMET03499 | DBMET03499 | |
| 0.119 | 0.024 | 0.121 | Somatostatin 1 agonist | 0.121 0.023 DBMET03499 | DBMET03499 | |
| 0.099 | 0.005 | 0.101 | GHS receptor agonist | 0.101 0.005 DBMET03499 | DBMET03499 | |
| 0.118 | 0.025 | 0.118 | Alpha 2d adrenoreceptor antagonist | 0.116 0.027 DBMET03499 | ||
| 0.113 | 0.023 | 0.118 | 3C-Like protease (SARS coronavirus) inhibitor | 0.118 0.02 DBMET03499 | DBMET03499 | |
| 0.097 | 0.007 | 0.097 | Growth hormone secretagogue receptor antagonist | 0.09 0.008 DBMET03499 | ||
| 0.109 | 0.022 | 0.129 | Histone deacetylase SIRT2 inhibitor | 0.129 0.012 DBMET03499 | DBMET03499 | |
| 0.139 | 0.053 | 0.141 | Cell adhesion inhibitor | 0.141 0.052 DBMET03499 | DBMET03499 | |
| 0.112 | 0.026 | 0.115 | Analgesic, opioid | 0.115 0.024 DBMET03499 | DBMET03499 | |
| 0.089 | 0.005 | 0.089 | Carbonic anhydrase I stimulant | 0.089 0.005 DBMET03499 | ||
| 0.103 | 0.021 | 0.104 | Sirtuin 1 inhibitor | 0.104 0.021 DBMET03499 | DBMET03499 | |
| 0.097 | 0.015 | 0.099 | Cathepsin E inhibitor | 0.099 0.014 DBMET03499 | DBMET03499 | |
| 0.098 | 0.018 | 0.099 | Trypsin inhibitor | 0.099 0.017 DBMET03499 | DBMET03499 | |
| 0.108 | 0.031 | 0.112 | Chymotrypsin inhibitor | 0.112 0.029 DBMET03499 | DBMET03499 | |
| 0.095 | 0.019 | 0.096 | Plasmin inhibitor | 0.096 0.018 DBMET03499 | DBMET03499 | |
| 0.091 | 0.022 | 0.095 | Cathepsin L inhibitor | 0.095 0.021 DBMET03499 | DBMET03499 | |
| 0.083 | 0.017 | 0.097 | Opioid mu receptor agonist | 0.097 0.014 DBMET03499 | DBMET03499 | |
| 0.075 | 0.011 | 0.075 | Carbonic anhydrase II stimulant | 0.075 0.011 DBMET03499 | ||
| 0.079 | 0.015 | 0.08 | Complement C3a chemotactic receptor antagonist | 0.08 0.014 DBMET03499 | DBMET03499 | |
| 0.07 | 0.007 | 0.07 | Growth hormone releasing factor agonist | 0.068 0.008 DBMET03499 | ||
| 0.072 | 0.01 | 0.111 | Melanocortin 5 antagonist | 0.111 0.007 DBMET03499 | DBMET03499 | |
| 0.082 | 0.024 | 0.085 | Plasminogen activator inhibitor | 0.085 0.023 DBMET03499 | DBMET03499 | |
| 0.077 | 0.02 | 0.083 | Opioid agonist | 0.083 0.018 DBMET03499 | DBMET03499 | |
| 0.062 | 0.007 | 0.063 | Bombesin 1 receptor antagonist | 0.063 0.007 DBMET03499 | DBMET03499 | |
| 0.06 | 0.006 | 0.084 | Neurokinin 1 agonist | 0.084 0.005 DBMET03499 | DBMET03499 | |
| 0.225 | 0.171 | 0.225 | Immunosuppressant | 0.222 0.174 DBMET03499 | ||
| 0.078 | 0.025 | 0.078 | Protease activated receptor antagonist | 0.072 0.032 DBMET03499 | ||
| 0.065 | 0.013 | 0.066 | Growth hormone release inhibitor | 0.066 0.013 DBMET03499 | DBMET03499 | |
| 0.072 | 0.022 | 0.074 | Kallikrein 1 inhibitor | 0.074 0.021 DBMET03499 | DBMET03499 | |
| 0.064 | 0.014 | 0.067 | Oxytocin agonist | 0.067 0.012 DBMET03499 | DBMET03499 | |
| 0.056 | 0.006 | 0.056 | Bradykinin B2 receptor agonist | 0.055 0.006 DBMET03499 | ||
| 0.065 | 0.016 | 0.065 | Erythropoietin receptor agonist | 0.063 0.016 DBMET03499 | ||
| 0.061 | 0.014 | 0.069 | Somatostatin 1 antagonist | 0.069 0.012 DBMET03499 | DBMET03499 | |
| 0.06 | 0.013 | 0.06 | Renin inhibitor | 0.059 0.013 DBMET03499 | ||
| 0.058 | 0.012 | 0.063 | Cholecystokinin B agonist | 0.063 0.011 DBMET03499 | DBMET03499 | |
| 0.066 | 0.02 | 0.069 | Kallikrein inhibitor | 0.069 0.019 DBMET03499 | DBMET03499 | |
| 0.058 | 0.013 | 0.064 | Somatostatin 2 antagonist | 0.064 0.011 DBMET03499 | DBMET03499 | |
| 0.046 | 0.002 | 0.106 | Melatonin 5 antagonist | 0.106 0.002 DBMET03499 | DBMET03499 | |
| 0.056 | 0.013 | 0.061 | Somatostatin 4 agonist | 0.061 0.012 DBMET03499 | DBMET03499 | |
| 0.066 | 0.023 | 0.067 | Angiotensin-converting enzyme inhibitor | 0.067 0.022 DBMET03499 | DBMET03499 | |
| 0.057 | 0.014 | 0.058 | Neurokinin 2 agonist | 0.058 0.014 DBMET03499 | DBMET03499 | |
| 0.067 | 0.025 | 0.071 | Urokinase inhibitor | 0.071 0.024 DBMET03499 | DBMET03499 | |
| 0.051 | 0.01 | 0.051 | Histamine H3 receptor agonist | 0.049 0.011 DBMET03499 | ||
| 0.06 | 0.02 | 0.061 | Farnesyltransferase inhibitor | 0.061 0.02 DBMET03499 | DBMET03499 | |
| 0.068 | 0.03 | 0.068 | Cathepsin B inhibitor | 0.065 0.032 DBMET03499 | ||
| 0.166 | 0.128 | 0.166 | Free radical scavenger | 0.154 0.14 DBMET03499 | ||
| 0.048 | 0.014 | 0.055 | Somatostatin agonist | 0.055 0.012 DBMET03499 | DBMET03499 | |
| 0.085 | 0.051 | 0.093 | Opioid kappa receptor antagonist | 0.093 0.042 DBMET03499 | DBMET03499 | |
| 0.051 | 0.017 | 0.057 | Oxytocin antagonist | 0.057 0.016 DBMET03499 | DBMET03499 | |
| 0.048 | 0.014 | 0.048 | Opioid delta receptor agonist | 0.048 0.014 DBMET03499 | ||
| 0.039 | 0.008 | 0.039 | Growth hormone release promoting | 0.036 0.008 DBMET03499 | ||
| 0.063 | 0.033 | 0.069 | Human rhinovirus A protease inhibitor | 0.069 0.029 DBMET03499 | DBMET03499 | |
| 0.041 | 0.011 | 0.041 | GHS receptor antagonist | 0.038 0.014 DBMET03499 | ||
| 0.058 | 0.029 | 0.063 | GP IIb/IIIa receptor antagonist | 0.063 0.027 DBMET03499 | DBMET03499 | |
| 0.042 | 0.014 | 0.042 | Bradykinin B2 receptor antagonist | 0.042 0.014 DBMET03499 | ||
| 0.061 | 0.033 | 0.062 | Cathepsin D inhibitor | 0.062 0.033 DBMET03499 | DBMET03499 | |
| 0.23 | 0.202 | 0.243 | Analgesic | 0.243 0.189 DBMET03499 | DBMET03499 | |
| 0.047 | 0.021 | 0.051 | Integrin alpha5beta1 antagonist | 0.051 0.017 DBMET03499 | DBMET03499 | |
| 0.042 | 0.017 | 0.048 | Somatostatin 5 antagonist | 0.048 0.014 DBMET03499 | DBMET03499 | |
| 0.064 | 0.04 | 0.065 | Caspase 9 inhibitor | 0.065 0.038 DBMET03499 | DBMET03499 | |
| 0.173 | 0.151 | 0.173 | Superoxide dismutase inhibitor | |||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase IV stimulant | 0.025 0.005 DBMET03499 | ||
| 0.042 | 0.022 | 0.042 | Glucagon-like peptide 1 receptor antagonist | 0.04 0.026 DBMET03499 | ||
| 0.036 | 0.017 | 0.036 | Calpain 1 inhibitor | 0.035 0.02 DBMET03499 | ||
| 0.056 | 0.037 | 0.056 | Bombesin 3 receptor antagonist | 0.056 0.038 DBMET03499 | ||
| 0.033 | 0.015 | 0.033 | Vasopressin 1B antagonist | 0.031 0.016 DBMET03499 | ||
| 0.059 | 0.04 | 0.061 | Aminopeptidase microsomal inhibitor | 0.061 0.039 DBMET03499 | DBMET03499 | |
| 0.031 | 0.013 | 0.031 | Antidiuretic hormone agonist | 0.03 0.014 DBMET03499 | ||
| 0.04 | 0.022 | 0.04 | Integrin alpha1beta1 antagonist | 0.039 0.023 DBMET03499 | ||
| 0.047 | 0.03 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.046 0.031 DBMET03499 | ||
| 0.031 | 0.015 | 0.031 | Vasopressin 1A agonist | 0.03 0.016 DBMET03499 | ||
| 0.045 | 0.029 | 0.052 | Integrin antagonist | 0.052 0.026 DBMET03499 | DBMET03499 | |
| 0.033 | 0.017 | 0.033 | Complement C5a chemotactic receptor antagonist | 0.033 0.017 DBMET03499 | ||
| 0.075 | 0.06 | 0.079 | Cell adhesion molecule inhibitor | 0.079 0.054 DBMET03499 | DBMET03499 | |
| 0.025 | 0.01 | 0.025 | Vasopressin 1 agonist | 0.024 0.011 DBMET03499 | ||
| 0.027 | 0.013 | 0.031 | Somatostatin 4 antagonist | 0.031 0.011 DBMET03499 | DBMET03499 | |
| 0.035 | 0.021 | 0.035 | Trypsin I inhibitor | 0.035 0.021 DBMET03499 | ||
| 0.021 | 0.008 | 0.022 | Glucagon agonist | 0.022 0.008 DBMET03499 | DBMET03499 | |
| 0.021 | 0.008 | 0.021 | KiSS-1 receptor antagonist | 0.021 0.008 DBMET03499 | ||
| 0.015 | 0.004 | 0.015 | Angiotensin AT2 receptor agonist | 0.014 0.004 DBMET03499 | ||
| 0.025 | 0.015 | 0.026 | Growth hormone releasing factor antagonist | 0.026 0.015 DBMET03499 | DBMET03499 | |
| 0.036 | 0.027 | 0.038 | Tryptase inhibitor | 0.038 0.024 DBMET03499 | DBMET03499 | |
| 0.14 | 0.132 | 0.14 | Catenin beta inhibitor | |||
| 0.029 | 0.021 | 0.03 | Factor VII inhibitor | 0.03 0.02 DBMET03499 | DBMET03499 | |
| 0.055 | 0.047 | 0.055 | Carbonic anhydrase stimulant | |||
| 0.059 | 0.05 | 0.063 | Selectin antagonist | 0.063 0.047 DBMET03499 | DBMET03499 | |
| 0.03 | 0.022 | 0.03 | Dipeptidyl peptidase I inhibitor | 0.03 0.022 DBMET03499 | ||
| 0.036 | 0.029 | 0.037 | Factor VIIa inhibitor | 0.037 0.028 DBMET03499 | DBMET03499 | |
| 0.027 | 0.019 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.075 | 0.068 | 0.075 | Neuropeptide Y antagonist | |||
| 0.038 | 0.032 | 0.042 | Neurokinin 2 antagonist | 0.042 0.028 DBMET03499 | DBMET03499 | |
| 0.016 | 0.012 | 0.016 | Vasopressin 2 agonist | 0.015 0.013 DBMET03499 | ||
| 0.017 | 0.013 | 0.018 | Protease activated receptor agonist | 0.018 0.012 DBMET03499 | DBMET03499 | |
| 0.033 | 0.029 | 0.033 | Cholecystokinin A antagonist | 0.032 0.03 DBMET03499 | ||
| 0.027 | 0.024 | 0.027 | Trypsin II inhibitor | 0.027 0.024 DBMET03499 | ||
| 0.034 | 0.031 | 0.037 | Antidiuretic hormone antagonist | 0.037 0.029 DBMET03499 | DBMET03499 | |
| 0.03 | 0.027 | 0.032 | Plasma kallikrein inhibitor | 0.032 0.025 DBMET03499 | DBMET03499 | |
| 0.009 | 0.007 | 0.009 | KiSS-1 receptor agonist | 0.009 0.007 DBMET03499 | ||
| 0.031 | 0.029 | 0.036 | Somatostatin 5 agonist | 0.036 0.023 DBMET03499 | DBMET03499 | |
| 0.034 | 0.033 | 0.034 | Cholecystokinin antagonist | |||
| 0.039 | 0.042 | 0.041 | Aminopeptidase N inhibitor | 0.041 0.04 DBMET03499 | DBMET03499 | |
| 0.016 | 0.019 | 0.018 | Somatostatin 3 antagonist | 0.018 0.016 DBMET03499 | DBMET03499 | |
| 0.018 | 0.026 | 0.021 | Motilin receptor agonist | 0.021 0.019 DBMET03499 | DBMET03499 | |
| 0.029 | 0.04 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.03 DBMET03499 | DBMET03499 | |
| 0.028 | 0.043 | 0.037 | Nicotinic receptor beta4 subunit antagonist | 0.037 0.026 DBMET03499 | DBMET03499 | |
| 0.107 | 0.123 | 0.139 | Diuretic | 0.139 0.086 DBMET03499 | DBMET03499 | |
| 0.047 | 0.067 | 0.063 | Cyclin A1 inhibitor | 0.063 0.033 DBMET03499 | DBMET03499 | |
| 0.028 | 0.073 | 0.044 | Nicotinic receptor alpha3 subunit antagonist | 0.044 0.03 DBMET03499 | DBMET03499 | |
| 0.06 | 0.111 | 0.107 | Aminopeptidase B inhibitor | 0.107 0.06 DBMET03499 | DBMET03499 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |